Skip to content

Clinical trials

Completed Metabolism, Inborn Errors trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Metabolism, Inborn Errors Status: Completed Country / region: Canada Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20081
20091
20141
20172

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Kastle Therapeutics, LLC2
Akcea Therapeutics1
Alexion Pharmaceuticals, Inc.1
Regeneron Pharmaceuticals1
Sumitomo Pharma Switzerland GmbH1
University of Washington1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Metabolism, Inborn Errors7
Genetic Diseases, Inborn6
Metabolic Diseases6
Lipid Metabolism Disorders5
Infant, Newborn, Diseases4
Lipid Metabolism, Inborn Errors4
Dyslipidemias3
Hyperlipidemias3
Hyperlipoproteinemias3
Congenital Abnormalities2

Trials

Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.